Hypnosis to Reduce Aromatase Inhibitor Pain and Improve Adherence

NACompletedINTERVENTIONAL
Enrollment

191

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

March 18, 2021

Study Completion Date

March 18, 2021

Conditions
Breast NeoplasmsMusculoskeletal Pain
Interventions
BEHAVIORAL

Hypnosis

"The hypnosis intervention involves three parts. First, participants will receive three, face-to-face hypnosis sessions delivered by doctoral-level psychology professionals. The sessions are based on materials developed by experienced psychologists in the Integrative Behavioral Medicine Program at the Icahn School of Medicine at Mount Sinai. Second, participants will be taught how to use hypnosis themselves (self-hypnosis) to help manage their pain. Third, participants will receive a hypnosis recording to listen to in-between sessions and throughout the course of the study. At home hypnosis practice will be recommended.~Participants will be asked to complete questionnaires over a period of 12 months."

BEHAVIORAL

Attention Control

"The attention control intervention involves three face-to-face meetings with a doctoral-level psychology professional. During these sessions, participants will be asked to discuss with the interventionist their experience of taking aromatase inhibitors and associated musculoskeletal pain. The interventionist will not lead the patient in imagery, relaxation, evaluation of thought processes, or even simple discussion. Rather interventionists will allow the patient to direct the flow of the conversation and will provide support and empathy. Interventionist contact time in AC sessions will be identical to that in the hypnosis group. Overall, the attention control intervention will control for professional attention.~Participants will be asked to complete questionnaires over a period of 12 months."

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT02657993 - Hypnosis to Reduce Aromatase Inhibitor Pain and Improve Adherence | Biotech Hunter | Biotech Hunter